Ultralife Corp (NASDAQ: ULBI) stock suffered a major decline of -11.0% on 3/12/24. The shares closed at $8.71. Moreover, exceptionally high trading volume at 241% of normal accompanied the decline. The stock has been exceptionally strong relative to the market over the last nine months but has declined -9.8% during the last week.
Current PriceTarget Research Rating
ULBI is expected to be a modest Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
Ultralife has a current Value Trend Rating of C (High Neutral). This rating combines contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Ultralife has a slightly negative Appreciation Score of 38 but a good Power Rating of 82, with the High Neutral Value Trend Rating the result.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment